Catalyst Wire Dossier Catalyst Wire Dossier

Thymosin Beta-4 Ophthalmic Solution

thymosin beta-4 · ReGenTree, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Thymosin Beta-4 Ophthalmic Solution, covering 2012-12-24 to 2012-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye [Phase 2]

See pricing